Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats?

Hypertension

Volumn 29, Issue 3, 1997, Pages 776-780

  Díez, Javier ^a   Panizo, Angel ^a   Hernández, Marta ^a   Pardo, Javier ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

apoptosis; hypertension, arterial; muscle, smooth, vascular

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEIN BCL 2; QUINAPRIL;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

EID: 0342506457     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.3.776     Document Type: Article

References (36)

1. Bennett MR, Evan GI. The molecular basis of apoptosis. Heart Failure. 1994;9:199-212.
2. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124:1-6.
3. Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer S. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334-336.
4. Oltvai Z, Milliman C, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-619.
5. Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell. 1994;79:189-192.
6. Bjorkerud S, Bjorkerud B, Joelsson M. Structural organization of reconstituted human arterial smooth muscle tissue. Arterioscler Thromb. 1994;14:644-651.
7. Bennett MR, Evan GI, Newby AC. Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ Res. 1994;74:525-536.
8. Cho A, Courtman DW, Langille BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 1995;76:168-175.
9. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
10. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A. 1991;88:6961-6965.
11. Krajewski S, Krajewski M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant negative inhibitor of Bcl-2. Am J Pathol. 1994;145:1323-1336.
12. Leszczynski D, Zhao Y, Luokkamäki M, Foegh ML. Apoptosis of vascular smooth muscle cells: protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am J Pathol. 1994;145:1265-1270.
13. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427-444.
14. Hamet P. Proliferation and apoptosis of vascular smooth muscle in hypertension. Curr Opin Nephrol Hypertens. 1995;4:1-7.
15. Panizo A, Pardo J, Hernández M, Galindo MF, Cenarruzabeitia E, Díez J. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens. 1995;8:815-822.
16. Lovenberg W. Techniques for the measurement of blood pressure. Hypertension. 1987;9(suppl I):I-5-I-6.
17. Cheung HS, Cushman DW. Inhibition of homogeneous angiotensin converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jaracaca. Biochim Biophys Acta. 1973;293:451-463.
18. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971;20:1637-1648.
19. Hurst PL, Lovell-Smith CJ. Optimized assay for serum angiotensin-converting enzyme activity. Clin Chem. 1980;27:2048-2056.
20. Panizo A, Pardo Mindán FJ, Galindo MF, Cenarruzabeitia E, Hernández M, Díez J. Are mast cells involved in hypertensive heart disease? J Hypertens. 1995;13:1201-1208.
21. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins, II: Distribution of filament proteins in normal tissues. Am J Pathol. 1984;114:309-321.
22. Reed JC, Meister L, Tanaka S, Cuddy M, Yum S, Geyer C, Pleasure D. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res. 1991;51:6529-6538.
23. Ruzicka M, Skarda V, Leenen FHH. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. Circulation. 1995;92:3568-3573.
24. Lyall F, Deehan MR, Greer IA, Boswell F, Brown WC, McInnes GT. Mechanical stretch increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells. J Hypertens. 1994;12:1139-1145.
25. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1419-1424.
26. Naftilan AJ, Pratt RE, Eldridge CS, Lin HL, Dzau VJ. Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension. 1989;13:706-711.
27. Bennett MR, Evan GI, Schwartz SM. Apoptosis in rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ Res. 1995;77:266-273.
28. Yuan J. Molecular control of life and death. Curr Opin Cell Biol. 1995;7:211-214.
29. Miyashita T, Krajewski S, Krajewski M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799-1805.
30. Hamet P, Richard L, Dam TV, Teiger E, Orlov SN, Gaboury L, Gossard F, Tremblay J. Apoptosis in target organs in hypertension. Hypertension. 1995;26:642-648.
31. Owens GK. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am J Physiol. 1989;257:H1755-H1765.
32. De Mey JGR, Dijkstra E, Fazzi G, Janssen G. Growth response in the arterial wall. Basic Res Cardiol. 1991;86(suppl 1):13-17.
33. Daemen MJAP, De Mey JGR. Regional heterogeneity of arterial structural changes. Hypertension. 1995;25(part 1):464-473.
34. Horiuchi M, Yamada T, Pollman MJ, Gibbons GH, Dzau VJ. Tyrosine phosphatase activation mediates the angiotensin II type 2 receptor induction of apoptosis. J Hypertens. 1996;14(suppl 1):S140. Abstract.
35. Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-α, and interleukin-1β. Arterioscler Thromb Vasc Biol. 1996;16:19-27.
36. Fukuo K, Hata S, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y, Morimoto S, Ogihara T. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension. 1996;27(part 2):823-826.